Novartis In-licenses COVID-19 Treatment Ensovibep from Molecular Partners - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Novartis in-licenses COVID-19 treatment ensovibep from Molecular Partners ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)